The Limited Times

Now you can see non-English news...

Covid: Ft, Oxford vaccine stimulates response in elderly

2020-10-26T12:32:46.647Z

Confirmed production of antibodies and T cells already seen in young people (ANSA)The Covid vaccine being studied by the University of Oxford and AstraZeneca would seem to give a strong immune response in the elderly. The Financial Times writes it, anticipating the results of the phase 3 clinical trial in progress. According to the newspaper, which cites 'two people with knowledge of the results', the vaccine stimulates the production of protective antibodies and T cells, a ne



The Covid vaccine being studied by the University of Oxford and AstraZeneca would seem to give a strong immune response in the elderly.

The Financial Times writes it, anticipating the results of the phase 3 clinical trial in progress.

According to the newspaper, which cites 'two people with knowledge of the results', the vaccine stimulates the production of protective antibodies and T cells, a necessary but not sufficient condition to establish efficacy and which does not provide any information on safety. The immune response is similar to that already seen in adults between 18 and 55 years, already described in July. These results, too, reports the FT, will soon be published in a scientific journal. The Oxford vaccine, in the development of which the Italian company Irbm also participates, is one of those in the most advanced stage of development at the moment, with the first data on safety and efficacy expected within this year. The vaccine test in the US has just resumed, after a stop for the analysis of some side effects reported by the company.


Source: ansa

All life articles on 2020-10-26

Similar news:

You may like

Life/Entertain 2020-10-26T12:32:46.647Z

Trends 24h

Life/Entertain 2020-11-25T01:05:42.372Z
Life/Entertain 2020-11-25T17:33:55.439Z

Latest

© Communities 2019 - Privacy